A non-catalytic role of IPMK is required for PLCγ1 activation in T cell receptor signaling by stabilizing the PLCγ1-Sam68 complex.
Autor: | Hong S; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Kim K; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Shim YR; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Park J; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Choi SE; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Min H; School of Biological Sciences, Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea., Lee S; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Song JJ; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Kang SJ; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Jeong WI; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea., Seong RH; School of Biological Sciences, Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea., Kim S; Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Youseong-Gu, Daejeon, 34141, Republic of Korea. seyunkim@kaist.ac.kr.; KAIST Institute for the BioCentury, KAIST, Daejeon, 34141, Republic of Korea. seyunkim@kaist.ac.kr.; KAIST Stem Cell Center, KAIST, Daejeon, 34141, Republic of Korea. seyunkim@kaist.ac.kr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cell communication and signaling : CCS [Cell Commun Signal] 2024 Oct 30; Vol. 22 (1), pp. 526. Date of Electronic Publication: 2024 Oct 30. |
DOI: | 10.1186/s12964-024-01907-0 |
Abstrakt: | Background: Phospholipase C gamma 1 (PLCγ1) is an important mediator of the T cell receptor (TCR) and growth factor signaling. PLCγ1 is activated by Src family kinases (SFKs) and produces inositol 1,4,5-triphosphate (InsP Methods: Concanavalin A (ConA)-induced acute hepatitis model was established in CD4 + T cell-specific IPMK knockout mice (IPMK ΔCD4 ). Histological analysis was performed to assess hepatic injury. Primary cultures of naïve CD4 + T cells were used to uncover the role of mechanisms of IPMK in vitro. Western blot analysis, quantitative real-time PCR, and flow cytometry were performed to analyze the TCR-stimulation-induced PLCγ1 activation and the downstream signaling pathway in naïve CD4 + T cells. Yeast two-hybrid screening and co-immunoprecipitation were conducted to identify the IPMK-binding proteins and protein complexes. Results: IPMK ΔCD4 mice showed alleviated ConA-induced acute hepatitis. CD4 + helper T cells in these mice showed reduced PLCγ1 Y783 phosphorylation, which subsequently dampens calcium signaling and IL-2 production. IPMK was found to contribute to PLCγ1 activation via the direct binding of IPMK to Src-associated substrate during mitosis of 68 kDa (Sam68). Mechanistically, IPMK stabilizes the interaction between Sam68 and to PLCγ1, thereby promoting PLCγ1 phosphorylation. Interfering this IPMK-Sam68 binding interaction with IPMK dominant-negative peptides impaired PLCγ1 phosphorylation. Conclusions: Our results demonstrate that IPMK non-catalytically promotes PLCγ1 phosphorylation by stabilizing the PLCγ1-Sam68 complex. Targeting IPMK in CD4 + T cells may be a promising strategy for managing immune diseases caused by excessive stimulation of TCR. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |